News from sangamo biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 18, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Participation In The 3rd Annual Regen Med Investor Day Meeting In New York

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Elizabeth Wolffe, Ph.D., Sangamo's vice president, corporate communications,...

Mar 09, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences CEO To Present State Of The Industry Address At Alliance For Regenerative Medicine's Advanced Therapies Summit

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that Edward Lanphier, Sangamo's president and CEO, will present an overview of the state of...

Feb 26, 2015, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed to Provide Functional Control of HIV

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the presentation of new clinical data from its Phase 1/2 clinical trial (SB-728-1101). The...

Feb 25, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Presentation At The Cowen And Company 35th Annual Health Care Conference

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress...

Feb 12, 2015, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Presents Data At 11th Annual WorldSymposium™ Meeting Supporting In Vivo Protein Replacement Platform Approach For The Treatment Of Lysosomal Storage Disorders

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced the presentation of preclinical data from its In Vivo Protein Replacement Platform (IVPRP)...

Feb 10, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Reports Fourth Quarter and Full Year 2014 Financial Results

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its fourth quarter and full year 2014 financial results and accomplishments. For the...

Feb 05, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Presentation At The 2015 Leerink Global Healthcare Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the...

Feb 04, 2015, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces FDA Acceptance of IND to Initiate Clinical Trial of its Novel ZFP Therapeutic® for Beta-Thalassemia

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that an Investigational New Drug (IND) application for the company's SB-BCLmR-HSPC genome...

Feb 03, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Fourth Quarter and Full Year 2014 Conference Call and Webcast

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) today announced that the company will release its fourth quarter and full year 2014 financial results...

Jan 12, 2015, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences To Highlight 2015 Catalysts And Advancement Of ZFP Therapeutic Programs At The 33rd Annual J.P. Morgan Healthcare Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that Edward Lanphier, Sangamo's president and CEO, will present an update on the Company's...

Jan 08, 2015, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces In-Licensing Of mRNA Delivery Technology And Expansion Of Therapeutic Pipeline Opportunities For Sangamo's In Vivo ZFN Genome-Editing Platform

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the company has in-licensed nanoparticle technology to enable systemic...

Jan 05, 2015, 16:15 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Presentation At The 33rd Annual J.P. Morgan Healthcare Conference

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the Company's...

Dec 08, 2014, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Presents New Data at American Society of Hematology Meeting Demonstrating Broad Application of ZFN Mediated Genome-Editing Approach to Therapeutics for Hemophilia and Lysosomal Storage Disorders

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the presentation of new preclinical data from its proprietary programs for the treatment of...

Nov 19, 2014, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that positive preclinical data from its joint program with Shire plc, to develop a novel ZFP...

Nov 10, 2014, 09:05 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences President and CEO Edward Lanphier to Serve as Chairman of the Alliance for Regenerative Medicine

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that Edward Lanphier, the Company's president and CEO, has been elected to serve as the next...

Oct 22, 2014, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Reports Third Quarter 2014 Financial Results

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its third quarter 2014 financial results and accomplishments. For the third quarter...

Oct 16, 2014, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences ZFP Therapeutic Program in HIV/AIDS Featured at Three Major Scientific Conferences in October 2014

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that Company scientists and clinicians, as well as academic collaborators, were invited...

Oct 15, 2014, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Third Quarter 2014 Conference Call and Webcast

Sangamo BioSciences, Inc. (NASDAQ: SGMO) today announced that the company will release its third quarter 2014 financial results after the market...

Sep 10, 2014, 07:00 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Target Date For First IND For Sangamo's In Vivo ZFN Genome-Editing Platform For Monogenic Diseases

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced plans to submit an Investigational New Drug (IND) application for the treatment of hemophilia B...

Sep 08, 2014, 07:00 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Presentation At ICAAC of New Clinical Data Demonstrating Sustained Functional Control of Viremia in Multiple HIV-Infected Subjects Treated with SB-728-T

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the presentation of new data demonstrating that a single infusion of Sangamo's novel ZFP...